HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Manfred Dietel Selected Research

Tyrosine Kinase Inhibitors

8/2015EGFR mutation status and first-line treatment in patients with stage III/IV non-small cell lung cancer in Germany: an observational study.
9/2012EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations.
4/2012Optimized algorithm for Sanger sequencing-based EGFR mutation analyses in NSCLC biopsies.
10/2010Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Manfred Dietel Research Topics

Disease

129Neoplasms (Cancer)
01/2020 - 01/2002
49Carcinoma (Carcinomatosis)
04/2019 - 02/2002
42Breast Neoplasms (Breast Cancer)
10/2016 - 02/2002
27Ovarian Neoplasms (Ovarian Cancer)
04/2019 - 01/2005
22Prostatic Neoplasms (Prostate Cancer)
05/2017 - 01/2003
20Colorectal Neoplasms (Colorectal Cancer)
11/2021 - 01/2002
20Neoplasm Metastasis (Metastasis)
12/2019 - 01/2004
15Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2021 - 01/2003
14Adenocarcinoma
12/2019 - 01/2004
9Carcinogenesis
04/2013 - 10/2002
8Disease Progression
02/2018 - 02/2005
6Stomach Neoplasms (Stomach Cancer)
05/2017 - 04/2006
6Pancreatic Neoplasms (Pancreatic Cancer)
09/2012 - 07/2002
5Lung Neoplasms (Lung Cancer)
08/2021 - 09/2009
5Melanoma (Melanoma, Malignant)
08/2019 - 01/2003
5Colonic Neoplasms (Colon Cancer)
09/2015 - 09/2005
4Endometrial Neoplasms (Endometrial Cancer)
11/2021 - 09/2008
4Residual Neoplasm
10/2015 - 06/2009
3Lymphoma (Lymphomas)
12/2009 - 09/2004
3Renal Cell Carcinoma (Grawitz Tumor)
12/2008 - 06/2008
2Microsatellite Instability
11/2021 - 07/2021
2Lymphatic Metastasis
05/2017 - 04/2006
2Triple Negative Breast Neoplasms
10/2016 - 08/2013
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2016 - 09/2009
2Ovarian Epithelial Carcinoma
10/2015 - 12/2009

Drug/Important Bio-Agent (IBA)

61Proteins (Proteins, Gene)FDA Link
11/2021 - 01/2002
25ParaffinIBA
01/2020 - 06/2002
24Messenger RNA (mRNA)IBA
04/2019 - 12/2002
16Biomarkers (Surrogate Marker)IBA
01/2020 - 08/2005
16Formaldehyde (Formol)FDA Link
01/2020 - 09/2003
15DNA (Deoxyribonucleic Acid)IBA
08/2021 - 10/2002
13RNA (Ribonucleic Acid)IBA
08/2021 - 01/2003
12Cisplatin (Platino)FDA LinkGeneric
12/2017 - 01/2005
12Pharmaceutical PreparationsIBA
12/2010 - 07/2002
11Hormones (Hormone)IBA
01/2015 - 12/2006
11Cyclooxygenase 2 (Cyclooxygenase-2)IBA
12/2009 - 01/2004
10Estrogen ReceptorsIBA
01/2017 - 03/2006
7PlatinumIBA
06/2016 - 03/2007
7Member 1 Subfamily B ATP Binding Cassette TransporterIBA
12/2009 - 02/2002
7Protein Isoforms (Isoforms)IBA
01/2009 - 09/2003
6Anaplastic Lymphoma KinaseIBA
11/2018 - 09/2012
6AnthracyclinesIBA
10/2016 - 01/2009
6taxaneIBA
10/2016 - 01/2009
6Biological ProductsIBA
01/2016 - 01/2006
6ErbB Receptors (EGF Receptor)IBA
03/2015 - 01/2010
5Immune Checkpoint InhibitorsIBA
11/2021 - 05/2016
5B7-H1 AntigenIBA
02/2018 - 01/2016
5AntibodiesIBA
01/2016 - 01/2005
5Estrogen Receptor alphaIBA
06/2015 - 09/2005
5Histone Deacetylases (Histone Deacetylase)IBA
04/2013 - 02/2008
5Histone Deacetylase InhibitorsIBA
11/2009 - 02/2008
4LigandsIBA
01/2019 - 11/2006
4Prostate-Specific Antigen (Semenogelase)IBA
05/2017 - 01/2008
4AntigensIBA
05/2017 - 01/2004
4Histones (Histone)IBA
12/2015 - 02/2005
4Tyrosine Kinase InhibitorsIBA
08/2015 - 10/2010
4Estrogens (Estrogen)FDA Link
06/2015 - 09/2005
4human ERBB2 proteinIBA
03/2015 - 10/2008
4Metalloproteases (Metalloproteinases)IBA
09/2012 - 12/2006
4EnzymesIBA
09/2012 - 09/2005
4Progesterone Receptors (Progesterone Receptor)IBA
11/2011 - 12/2006
4Paclitaxel (Taxol)FDA LinkGeneric
06/2009 - 01/2005
4Mitoxantrone (Novantrone)FDA LinkGeneric
04/2009 - 02/2002
4ELAV-Like Protein 1IBA
02/2008 - 01/2004
4Polo-Like Kinase 1IBA
04/2006 - 08/2004
4Complementary DNA (cDNA)IBA
01/2006 - 11/2002
3Phosphotransferases (Kinase)IBA
01/2020 - 04/2005
3LipidsIBA
11/2017 - 09/2008
3Glutathione S-Transferase piIBA
10/2015 - 09/2005
3Poly(ADP-ribose) Polymerase InhibitorsIBA
10/2012 - 06/2011
3leptomycin BIBA
07/2011 - 02/2008
3Trastuzumab (Herceptin)FDA Link
09/2010 - 09/2004
3Transcription Factors (Transcription Factor)IBA
04/2010 - 11/2006
3ATP-Binding Cassette Transporters (ABC Transporters)IBA
12/2009 - 02/2002
3multidrug resistance-associated protein 1IBA
12/2009 - 02/2002
3Etoposide (VP 16)FDA LinkGeneric
07/2009 - 04/2006
3Fluorouracil (Carac)FDA LinkGeneric
02/2009 - 04/2006
3SteroidsIBA
01/2009 - 10/2004
3DisintegrinsIBA
11/2008 - 12/2006
3Cell Adhesion MoleculesIBA
08/2008 - 01/2003
3Monoclonal AntibodiesIBA
11/2006 - 01/2005
2pembrolizumabIBA
11/2021 - 07/2021
2dostarlimabIBA
11/2021 - 07/2021
2tyrosine receptor (receptor, tyrosine)IBA
01/2020 - 01/2020
2Epidermal Growth Factor (EGF)IBA
01/2019 - 02/2017
2Androgen Receptors (Androgen Receptor)IBA
05/2017 - 12/2015
2prostatic acid phosphataseIBA
05/2017 - 05/2009
2prosteinIBA
05/2017 - 02/2013
2Keratin-5 (Keratin 5)IBA
01/2017 - 01/2009
2Mitogen-Activated Protein KinasesIBA
09/2015 - 12/2002
2Glutamine (L-Glutamine)FDA Link
04/2015 - 12/2013

Therapy/Procedure

53Therapeutics
01/2020 - 01/2004
22Drug Therapy (Chemotherapy)
05/2017 - 11/2002
10Prostatectomy (Retropubic Prostatectomy)
03/2016 - 01/2008
7Neoadjuvant Therapy
10/2016 - 01/2009
4Precision Medicine
01/2019 - 01/2014
4Immunotherapy
01/2019 - 01/2016
3Adjuvant Chemotherapy
04/2015 - 12/2009
3Aftercare (After-Treatment)
09/2011 - 02/2005
2Liver Transplantation
10/2018 - 09/2015